Updates

Areas of Research Bone Tumors

<p>Bone Tumors</p>

We are advancing discovery and improving outcomes in pediatric bone tumors.

The research program within the Bone Tumor Program brings together laboratory scientists, translational investigators, and clinicians around a shared goal: improving outcomes for children with bone tumors. Through close collaboration and a patient‑centered mission, the team is committed to developing therapies that are both more effective and less toxic.

Defining the Biology of Bone Tumors

Current research efforts focus on uncovering the pathogenesis, biology, and malignant drivers of pediatric bone tumors, with particular attention to mechanisms underlying metastatic disease. Studies employ molecular genetic analyses alongside genomic and proteomic approaches to better predict tumor behavior and identify vulnerabilities that may inform precision treatment strategies.

Translating Science into Clinical Impact

The Bone Tumor Program is uniquely positioned to bridge basic science discovery and clinical innovation. Investigators are actively developing novel immunotherapeutic clinical trials for patients with recurrent or refractory disease. Close affiliations with Baylor College of Medicine—one of the nation’s leading medical schools—and Texas Children’s Hospital, one of the largest pediatric hospitals in the United States, create a robust environment for collaborative research and improved patient outcomes.

Our Researchers

Director, Bone Tumor Program

Lisa L. Wang, MD

Hematology-Oncology

Nabil M. Ahmed, MD

Arianexys Aquino-Lopez, MD, PhD

Atreyi Dasgupta, PhD

Meenakshi G. Hegde, MD

Sarah S. Kappa, MD

Chris Tsz-Kwong Man, PhD

Matthew T. McEvoy, MD

Shoba A. Navai, MD

Bilal A. Omer, MD

Debananda Pati, PhD

Nino C. Rainusso, MD

Pulivarthi H. Rao, PhD

Andrew A. Wahba, MD

Pathology

John M. Hicks, MD, PhD, DDS

Dolores H. Lopez-Terrada, MD, PhD

Surgical Oncology

Sanjeev A. Vasudevan, MD

Top 10 in Cancer

Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for nine consecutive years

Areas of Research in Cancer and Blood Disorders

Adolescent Hematology and Gynecology Bone Marrow Failure Bone Tumors Brain and Spinal Cord Tumors Cancer Genetics and Genomics Cancer Survivorship Cell and Gene Therapy Cell Therapy and Bone Marrow Transplant Developmental Therapeutics Epidemiology (Cancer and Hematology) Hemostasis and Thrombosis Histiocytosis ITP and Immune Hematology Immunotherapy Leukemia Liver Tumors Lymphoma Neuroblastoma Precision Oncology Rare Tumors Retinoblastoma Sickle Cell Disease and Thalassemia Soft Tissue Sarcoma Solid Tumors Thyroid Tumors

Adolescent Hematology and Gynecology Bone Tumors Cancer Genetics and Genomics Cell and Gene Therapy Developmental Therapeutics Hemostasis and Thrombosis ITP and Immune Hematology Leukemia Lymphoma Precision Oncology Retinoblastoma Soft Tissue Sarcoma Thyroid Tumors Bone Marrow Failure Brain and Spinal Cord Tumors Cancer Survivorship Cell Therapy and Bone Marrow Transplant Epidemiology (Cancer and Hematology) Histiocytosis Immunotherapy Liver Tumors Neuroblastoma Rare Tumors Sickle Cell Disease and Thalassemia Solid Tumors

Adolescent Hematology and Gynecology Brain and Spinal Cord Tumors Cell and Gene Therapy Epidemiology (Cancer and Hematology) ITP and Immune Hematology Liver Tumors Precision Oncology Sickle Cell Disease and Thalassemia Thyroid Tumors Bone Marrow Failure Cancer Genetics and Genomics Cell Therapy and Bone Marrow Transplant Hemostasis and Thrombosis Immunotherapy Lymphoma Rare Tumors Soft Tissue Sarcoma Bone Tumors Cancer Survivorship Developmental Therapeutics Histiocytosis Leukemia Neuroblastoma Retinoblastoma Solid Tumors

Texas Children’s Hospital Stay in touch